Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seizures | 6 | 2018 | 67 | 0.810 |
Why?
|
| Epilepsy | 4 | 2016 | 41 | 0.550 |
Why?
|
| Epilepsy, Temporal Lobe | 4 | 2022 | 16 | 0.480 |
Why?
|
| Electroencephalography | 7 | 2018 | 108 | 0.460 |
Why?
|
| Temporal Lobe | 3 | 2016 | 22 | 0.310 |
Why?
|
| Psychophysiologic Disorders | 2 | 2016 | 5 | 0.290 |
Why?
|
| Epilepsies, Partial | 2 | 2018 | 3 | 0.270 |
Why?
|
| Seizures, Febrile | 1 | 2022 | 1 | 0.230 |
Why?
|
| Encephalocele | 2 | 2022 | 4 | 0.200 |
Why?
|
| Brain | 2 | 2018 | 1268 | 0.180 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2018 | 1 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 468 | 0.170 |
Why?
|
| Anticonvulsants | 2 | 2016 | 34 | 0.170 |
Why?
|
| Cranial Fossa, Middle | 1 | 2015 | 1 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2022 | 1349 | 0.140 |
Why?
|
| Neurology | 1 | 2015 | 12 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 141 | 0.130 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 118 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2015 | 82 | 0.130 |
Why?
|
| Leishmania | 2 | 2007 | 17 | 0.130 |
Why?
|
| Adult | 11 | 2022 | 11034 | 0.120 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 79 | 0.120 |
Why?
|
| Hospitalization | 1 | 2015 | 370 | 0.100 |
Why?
|
| Female | 12 | 2022 | 19873 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 465 | 0.100 |
Why?
|
| Middle Aged | 9 | 2018 | 9642 | 0.100 |
Why?
|
| Functional Laterality | 2 | 2009 | 75 | 0.100 |
Why?
|
| Male | 10 | 2022 | 18870 | 0.090 |
Why?
|
| Flatulence | 1 | 2009 | 3 | 0.090 |
Why?
|
| Insurance, Major Medical | 1 | 2009 | 5 | 0.090 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2009 | 13 | 0.090 |
Why?
|
| Hypertension | 1 | 2016 | 770 | 0.090 |
Why?
|
| Aphasia | 1 | 2008 | 2 | 0.090 |
Why?
|
| Amnesia | 1 | 2008 | 8 | 0.090 |
Why?
|
| Status Epilepticus | 1 | 2008 | 11 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2022 | 1961 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 188 | 0.080 |
Why?
|
| Humans | 13 | 2022 | 34853 | 0.080 |
Why?
|
| Metalloendopeptidases | 1 | 2007 | 15 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2006 | 8 | 0.080 |
Why?
|
| Hand | 1 | 2006 | 23 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2008 | 333 | 0.070 |
Why?
|
| Zinc | 1 | 2007 | 114 | 0.070 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 170 | 0.070 |
Why?
|
| Sclerosis | 1 | 2022 | 6 | 0.060 |
Why?
|
| Young Adult | 3 | 2018 | 4012 | 0.060 |
Why?
|
| Thionucleotides | 1 | 2001 | 8 | 0.050 |
Why?
|
| Polylysine | 1 | 2001 | 8 | 0.050 |
Why?
|
| Ribonuclease H | 1 | 2001 | 11 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2001 | 17 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1999 | 58 | 0.040 |
Why?
|
| Spermatozoa | 1 | 1999 | 191 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 203 | 0.040 |
Why?
|
| Tennessee | 1 | 2016 | 59 | 0.040 |
Why?
|
| Aged | 3 | 2016 | 6448 | 0.040 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2015 | 1 | 0.030 |
Why?
|
| Meningitis | 1 | 2015 | 8 | 0.030 |
Why?
|
| Craniotomy | 1 | 2015 | 4 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 841 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 211 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1999 | 653 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 5035 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 606 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 1353 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 1422 | 0.030 |
Why?
|
| Macrophages | 2 | 2007 | 431 | 0.020 |
Why?
|
| Child | 2 | 2009 | 2875 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2009 | 12 | 0.020 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2008 | 1 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 8 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2008 | 49 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 255 | 0.020 |
Why?
|
| Zinc Sulfate | 1 | 2007 | 2 | 0.020 |
Why?
|
| Automatism | 1 | 2006 | 1 | 0.020 |
Why?
|
| Dystonia | 1 | 2006 | 3 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 2006 | 6 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2006 | 22 | 0.020 |
Why?
|
| Biological Availability | 1 | 2007 | 84 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 84 | 0.020 |
Why?
|
| Protective Agents | 1 | 2007 | 22 | 0.020 |
Why?
|
| Infant | 1 | 2009 | 1014 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2009 | 1318 | 0.020 |
Why?
|
| Hippocampus | 1 | 2008 | 546 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 2333 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 1681 | 0.010 |
Why?
|
| Germ-Free Life | 1 | 2001 | 3 | 0.010 |
Why?
|
| Leishmaniasis | 1 | 2001 | 6 | 0.010 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2001 | 14 | 0.010 |
Why?
|
| Phagosomes | 1 | 2001 | 30 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 62 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 137 | 0.010 |
Why?
|
| Liposomes | 1 | 2001 | 107 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2001 | 121 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 342 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 275 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 423 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 496 | 0.010 |
Why?
|
| Alu Elements | 1 | 1999 | 8 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2001 | 182 | 0.010 |
Why?
|
| United States | 1 | 2009 | 3894 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 649 | 0.010 |
Why?
|
| BRCA2 Protein | 1 | 1999 | 37 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 87 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 269 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 480 | 0.010 |
Why?
|
| Hela Cells | 1 | 1999 | 344 | 0.010 |
Why?
|
| Breast | 1 | 1999 | 134 | 0.010 |
Why?
|
| Animals | 2 | 2007 | 14307 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 932 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 484 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 1124 | 0.010 |
Why?
|
| DNA | 1 | 1999 | 549 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 1490 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 1300 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 522 | 0.010 |
Why?
|
| Cell Line | 1 | 1999 | 1289 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 781 | 0.010 |
Why?
|
| Mice | 1 | 2001 | 5668 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 1426 | 0.010 |
Why?
|